Stephen B. Shrewsbury - Mar 29, 2022 Form 4 Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Role
Chief Medical Officer
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Mar 29, 2022
Transactions value $
$48,474
Form type
4
Date filed
3/30/2022, 09:54 PM
Previous filing
Jan 28, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMPL Common Stock Options Exercise $48.5K +24.6K +33.53% $1.97 98K Mar 29, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Options Exercise $0 -24.6K -100% $0.00* 0 Mar 29, 2022 Common Stock 24.6K $1.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested and exercisable.